Long-acting cabotegravir and rilpivirine may be feasible for people without viral suppression
A cure must be a cure for all: why more HIV cure research in Africa is needed
Social support can buffer the effects of stigma on suicidality among young people living with HIV
Package of person-centred care improves viral suppression for young people living with HIV in Kenya and Uganda
The challenges integrating U=U into HIV care around the world
Rate of neural tube defects is no higher on dolutegravir
We still have no HIV cure. But we have a better strategy for finding one
Broader hepatitis C treatment not leading to more reinfections in people with HIV
Injectable PrEP is just as effective for transgender women as it is for gay men, study analysis finds
